Free press releases distribution network?

More news: Health/Surgery
Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Combination Vaccines Hold Potential in the South African Paediatric Vaccine Market - Combination paediatric vaccines are rapidly climbing the technology ladder as they have the ability to increase the immunisation coverage rate by lowering the amount of injections needed
Combination Vaccines Hold Potential in the South African Paediatric Vaccine Market

 

PRZOOM - /newswire/ - Cape Town, South Africa, 2008/03/18 - Combination paediatric vaccines are rapidly climbing the technology ladder as they have the ability to increase the immunisation coverage rate by lowering the amount of injections needed.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Unfortunately, however, the South African public sector has limited access to this technology due to its slow adoption rate of new technology and cost constraints.

Manufacturers are therefore challenged to lower their manufacturing costs and shift their revenue models to high-volume, low-margin products to suit the needs of the public sector and vaccinate the South African population against the necessary range of diseases.

New analysis from Frost & Sullivan, Strategic Analysis of the South African Paediatric Vaccines Markets, finds that this market earned revenues of $33.18 million in 2006 and estimates this to double by 2012. This is due to the expected launches of new vaccines between now and 2012 and the anticipated adoption of new combination and unique extended immunisation programme (EPI) vaccines.

"The current trend in the paediatric vaccine market is to combine existing vaccines," notes Frost & Sullivan Research Analyst Lizelle Wentzel. "These combination vaccines have caused a substantial expansion in market revenues, and growth in the South African private sector has increased significantly."

Patients in the private sector pay a high premium for the luxury of immunising their children against a broad range of diseases in one go.

Combination vaccines allow a higher coverage rate due to the lower number of injections needed per immunisation. Parents don't have to queue several times at clinics to ensure their child's proper vaccination, since some of these combined vaccines can contain as many as seven different antigens. Combination vaccines also contain less antigen, but induce the appropriate immune response needed for full protection.

In South Africa, the biggest challenge is to serve the public market through the government's EPI. Although revenues are high, volumes are low in the private sector. In the public sector, this model is reversed. Government's price-sensitive contracts, slow adoption of new technology and question marks around the disease burden of these new vaccines, make it challenging for manufacturers to supply paediatric vaccines to the public sector.

"The government revises the EPI programme annually, but due to tight budget allocations, the process of adopting new vaccines into the programme relies on the cost of the vaccines and the severity of the disease burden that can be prevented," explains Wentzel.

Vaccine manufacturers can overcome this challenge by reducing the manufacturing costs of vaccines. This presents a challenge in itself.

"Optimising processes in research and development to be more cost effective will allow manufacturers to reduce the price of paediatric vaccines and boost their chances of entering the EPI programme," states Wentzel. "Apart from cost, it is important to justify the vaccine. Paediatric vaccines are only accepted by the government if the specific disease burden covered by the vaccine is severe enough, which is where combination and 'novel' vaccines can play a huge role."

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the South African paediatric vaccines markets, then send an email to Patrick Cairns, Corporate Communications, at patrick.cairns[.]frost.com, your full name, company name, title, telephone number, company email address, company website, city, state and country. Upon receipt of the above information, an overview will be sent to you by email.

Strategic Analysis of the South African Paediatric Vaccines Markets is part of the Pharmaceutical & Biotechnology Growth Partnership Services Programme, which also includes research in the following markets: World Adult Infectious Diseases Vaccines Market, European Vaccines Market, Emerging Vaccines and Therapies, World Speciality Vaccine Market, World Regional Travel Vaccine Market, US Cancer Vaccine Market, and various others. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

Frost & Sullivan, the Global Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.

Strategic Analysis of the South African Paediatric Vaccines Markets - M1A7

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Combination Vaccines Hold Potential in the South African Paediatric Vaccine Market

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Frost & Sullivan |
Contact: Patrick Cairns 
+27 18 468 2315 patrick.cairns[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Health/Surgery Most Recent Related Press Releases:

Sustainable Alternatives to Polyvinylidene Chloride-coated Films Create Growth Opportunities & Transform the Food Packaging Markets in Western Europe
RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan Has Developed A Way to Engineer Glycan Complexes Clusters of Sugar Chains
The Clinicians of Longs Peak Emergency Physicians Join US Acute Care Solutions
Frost & Sullivan Recognizes BroadReach for Improving the Health and Wellbeing of Underserved Populations
Silver Spring Emergency Physicians Join US Acute Care Solutions
Stress Light Therapy Launches Crowd-Funded Campaign on Indiegogo.com
Frost & Sullivan Names Optum 2016 North America Company of the Year for Population Health Management
R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform
GE to Invest €150 Million in Biopharmaceutical Manufacturing Campus in Cork, Ireland, and Establish Advanced Manufacturing Training Centre At NIBRT
Ultimate Medical Group Announces A New Regenerative Medicine Division

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  Triggr & Bloom

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today